Categories: ProductTechnology
Nammi Therapeutics is an immunotherapy company developing first in class products for the treatment of cancer. We are developing products that focus immune activation at the site of tumors, sparing the life-changing side effects of systemic immune activation.
Investors 1
Mentions in press and media 2
| Date | Title | Description |
| 06.08.2024 | Nammi Therapeutics Completes Series B Funding | Nammi Therapeutics, Inc., a Los Angeles, CA-based immuno-oncology company, received $1M in investment commitment by the Myeloma Investment Fund (MIF).
The investment was part of a $30M Series B financing round.
Led by David Stover, Ph.D., P... |
| - | Nammi Therapeutics | “Nammi Therapeutics is an immunotherapy company developing first in class products for the treatment of cancer. We are developing products that focus immune activation at the site of tumors, sparing the life-changing side effects of systemi... |
Reviews 0
